Which immunosuppressive drugs are successful in treating severe ocular Behcets disease

Which immunosuppressive agents are reported to be successful in treating severe ocular Behcets disease?

• Topical (anterior uveitis), intraocular, and systemic corticosteroids (posterior involvement).

• Azathioprine, 2.5 mg/kg per day should be combined with corticosteroids for posterior involvement (uveitis, retina, optic nerve).

• Anti-TNFα therapy: Infliximab (5 mg/kg IV) is best. Use in combination with azathioprine or other disease-modifying antirheumatic drugs.

• Cyclosporine, 2 to 5 mg/kg per day, can be added to azathioprine and anti-TNFα therapy. Cyclosporine should be used with caution in patients with CNS Behçet’s disease because it can worsen CNS symptoms. Tacrolimus, 0.1 mg/kg per day, can be used as an alternative to cyclosporine.

• Interferon-α is a good alternative but should not be used with azathioprine due to additive myelotoxicity.

• Chlorambucil and cyclophosphamide are salvage therapies.

• Others: methotrexate, mycophenolate mofetil, anakinra, tocilizumab, and rituximab have been used successfully in a few patients.

15585

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

15856